Testing kits are designed to isolate human DNA from formalin-fixed and paraffin-embedded tissues (FFPE-blocks).
The testing kit is intended for collection, transportation and isolation of DNA from clinical samples. The kit includes test tubes with the DNA-Fast reagent which are recommended to be transferred to the treatment rooms of clinics as containers for taking, storing and transporting biological samples for PCR analysis.
The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the EGFR gene mutation status to determine indications for targeted therapy.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the NRAS gene mutation status to determine indications for targeted therapy.
The kits can't be used for diagnostics of any pathology and are designed only for qualitative determination of the status of mutations to determine indications for targeted therapy.